Replies to post #17576 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

There has been an absolute void of discussion on why Sandoz/Momenta has not been able to compete in the enoxaparin market. Momenta's enoxaparin has turned from the initial gold mine to a absolute liability.

Will any future endeavors bee different?